Evaxion to present EVX-04 leukemia vaccine data at EHA 2026 Congress
Evaxion A/S (NASDAQ: EVAX) will present new preclinical data for its EVX-04 therapeutic vaccine targeting acute myeloid leukemia at the ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
